Intra-aortic balloon pump (IABP) therapy increases bleeding and in-hospital mortality when used during percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS) or those ...
Munich, Germany – A balloon pump inserted in the aorta is currently the most widely used support device in the treatment of cardiogenic shock and, since its introduction in 1968, has been used in ...
Announcing a new article publication for Cardiovascular Innovations and Applications journal. An intra-aortic balloon pump (IABP) is the device most frequently used as a bridge to surgical repair in ...
PARIS — Early implantation of an intra-aortic balloon pump (IABP) in patients with decompensated heart failure (HF) and low output provided more effective treatment than inotropic agents in a small ...
The Benchmark Counterpulsation Outcomes Registry is perhaps the most robust barometer of real-world contemporary IABP practice we have at our disposal. The first report, published in 2001, documented, ...
WAYNE, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced FDA 510(k) clearance of the AC3 Range™ Intra-Aortic ...
Holger Thiele, MD, of the University of Leipzig Heart Center, Germany, gives an interview at the European Society of Cardiology Congress 2012 about the large-scale trial he and his colleagues ...
IV iron supplementation in HFrEF patients showed a 21% reduction in cardiovascular death or first HF hospitalization, despite not meeting primary endpoints. Intra-aortic balloon pump did not ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback